HomeTagsCybersecurity

cybersecurity

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Is Singapore’s Defence Surge A Temporary Spike Or A Permanent Structural Shift?

https://open.spotify.com/episode/6h424sB5CIQZwa6PQEKEWv?si=076ee9e376f44d71 Why the Death of the "Peace Dividend" is a Multi-Decade Tailwind for Defense Industrials In...
SGX-LISTED COMPANIES

Is Multi-Chem The Next Big Tech Play? – FY2025

https://open.spotify.com/episode/6bsUdttNHw2Cmt7zvBx2mx?si=5e9cdf1ae09c4cc0 5 Surprising Takeaways from Multi-Chem’s 2025 Shift Introduction: To the casual observer, the name "Multi-Chem Limited"...
SGX-LISTED COMPANIES

StarHub Is Entering What Leadership Calls The “Harvest” Phase – FY2025

5 Things We Learned from StarHub’s FY2025 Results The modern telecommunications landscape is defined by...
Financial Services

Standard Chartered doubles down on responsible AI to tackle future threats

Overview: Standard Chartered targets zero false positives in transactions AI-driven cybersecurity aims to reduce client friction Three-pillar...
Education

Kaspersky expands cybersecurity education to tackle rising digital risks

Overview: Kaspersky is expanding its cybersecurity education to address the rising digital risks that come...
Technology

Kaspersky cautions cybersecurity is weakest when mobile users travel abroad

Overview: Kaspersky's Choon Hong Chee highlights the cybersecurity risks for mobile users traveling abroad, specifically...

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...